Preclinical models are relatively underutilized and underfunded resources for modeling the pathogenesis and prevention of ovarian cancers. Several reviews have detailed the numerous published models of ovarian cancer. In this review, we will provide an overview of experimental model systems, their strengths and limitations, and use selected models to illustrate how they can be used to address specific issues about ovarian cancer pathogenesis. We will then highlight some of the preclinical prevention studies performed to date and discuss experiments needed to address important unanswered questions about ovarian cancer prevention strategies.
Anthony N Karnezis, Kathleen R Cho. Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention. Clinical obstetrics and gynecology. 2017 Dec;60(4):789-800
PMID: 28719396
View Full Text